Stay updated with breaking news from Accurium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug Administration
SMSF services provider has provided an explanation on whether an SMSF can use the segregated method where a fund that’s solely in retirement phase receives a contribution. In a live Q&A webinar, A
Eczacibasi-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177Lu (n.c.a. 177Lu) cutting-edge production technology LuMagic®. This agreement will enable transfer of relevant equipment and supply from Monrol to Curium.
Eczacibasi-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177Lu
Investegate announcements from Curium, Curium to become major player in the supply on non carrier added Lu-177